The molecular cause of this process is unknown but could be related to nonreceptor site binding/activation of G protein subunit alpha q (GNAQ) or other impacts on epidermal growth factor receptor (EGFR), Src, and tyrosine kinase expressed in hepatocellular carcinoma (TEC) family kinases. The gene discussed is EGFR; the disease is hepatocellular carcinoma.